4//SEC Filing
FISHMAN ROBERT S 4
Accession 0000899243-18-016051
CIK 0001088856other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:07 PM ET
Size
9.3 KB
Accession
0000899243-18-016051
Insider Transaction Report
Form 4
FISHMAN ROBERT S
10% Owner
Transactions
- Sale
Common Stock
2018-06-07$18.23/sh−8,000$145,826→ 0 total - Exercise/Conversion
Common Stock
2018-06-07$3.51/sh+8,000$28,080→ 8,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-06-07−8,000→ 369,000 totalExercise: $3.51Exp: 2025-09-29→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $17.90 to $18.93 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- [F3]Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number at the first anniversary of September 28, 2015. Thereafter, 1/48th of the total number of shares subject to this option grant vests and becomes exercisable on each monthly anniversary, so that the total number of shares subject to this option becomes fully vested and exercisable on September 28, 2019.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001232237
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:07 PM ET
- Size
- 9.3 KB